Disrupted HIV care during COVID-19 pandemic associated with increased disabilities among people living with HIV in Belize.

Publication date: Jan 24, 2025

The COVID-19 pandemic may have impacted disabilities among people living with HIV; however, data on the association between COVID-19 pandemic-related healthcare disruptions and disabilities among people living with HIV is limited. We aimed to evaluate the association between COVID-19-affected HIV care behaviors and disability domains among people living with HIV in Belize. A cross-sectional study was conducted at the Western Regional Hospital and Southern Regional Hospital between August and October 2021 among people living with HIV in Belize aged ≥ 21 years and on antiretroviral therapy. A self-reported questionnaire captured data on demographic and clinical characteristics (gender, age, ethnicity, marital status, employment, education, CD4 count, and viral load), COVID-19-affected HIV care behaviors, and disability across six domains (physical, cognitive, and mental-emotional symptoms and impairments; uncertainty; difficulties carrying out day-to-day activities; and social inclusion challenges) using the Short-Form HIV Disability Questionnaire. Univariate and multivariate logistic regression analyses were employed to analyze the data. Of the 489 participants, 276 (56. 4%) were women and 213 (43. 6%) were men. After adjusting for covariates, (age, gender, employment, CD4 count, viral load, COVID-19-affected HIV care behaviours), our results showed that people living with HIV, whose HIV care behaviors were greatly affected by COVID-19, were more likely to have disabilities across various domains: physical (adjusted odds ratio (AOR): 1. 61, 95% confidence interval (CI): 1. 08-2. 41, p = 0. 018), cognitive (AOR: 2. 49, 95% CI: 1. 58-3. 94, p 

Open Access PDF

Concepts Keywords
Aged21 Adult
Belize Belize
Hiv Care behaviour
October COVID-19
Therapy COVID-19
Cross-Sectional Studies
Disabilities
Female
Function limitation
HIV Infections
Humans
Male
Middle Aged
Pandemic
Pandemics
Persons with Disabilities
SARS-CoV-2
Surveys and Questionnaires

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH marital status
disease MESH viral load
disease MESH uncertainty
disease IDO immunodeficiency
drug DRUGBANK Coenzyme M
disease MESH chronic diseases
disease MESH anxiety
disease MESH depression
disease IDO susceptibility
disease IDO country
disease MESH lost to follow up
disease IDO process
disease MESH HIV infection
pathway REACTOME HIV Infection
disease MESH educational level
pathway KEGG Coronavirus disease
disease MESH complications
disease MESH AIDS
drug DRUGBANK Water
pathway KEGG Viral replication
disease MESH lifestyles
disease MESH infections
disease MESH Tuberculosis
pathway KEGG Tuberculosis
disease MESH emergencies
disease MESH coinfection
disease MESH psychological distress
drug DRUGBANK Acetylcysteine
pathway REACTOME Release
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)